查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607963

心臟病診斷市場：通過測試、最終用戶 - 2025-2030 年全球預測

Heart Attack Diagnostics Market by Test (Blood Tests, Echocardiogram, Electrocardiogram), End User (Ambulatory Surgical Centers, Diagnostics Centers, Hospital & Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心臟病診斷市值為139.7億美元，預計到2024年將達到149.6億美元，複合年成長率為7.68%，預計到2030年將達到234.7億美元。

心臟病診斷市場包括各種旨在快速準確識別心肌梗塞的工具和技術。該領域包括心電圖等診斷測試、肌鈣蛋白等心臟生物標記的血液測試以及先進的診斷成像技術。這項需求源於對早期準確檢測的迫切需要，以改善患者預後並降低死亡率。這些診斷的應用範圍很廣，包括急診室就診、高風險個體的例行檢查以及持續監測技術。從最終用途來看，醫院、診所和研究機構是主要用戶，但個人健康監測設備在家庭醫療保健環境中的應用也呈現成長趨勢。

主要市場統計
基準年[2023] 139.7億美元
預測年份 [2024] 149.6億美元
預測年份 [2030] 234.7億美元
複合年成長率（%） 7.68%

關鍵的成長要素包括由於生活方式的改變、人口老化以及可提供更快、更準確結果的診斷技術的進步，心血管疾病的盛行率不斷增加。新的商機在於人工智慧和機器學習的整合，以增強診斷能力和開發非侵入性就地檢驗解決方案。公司可以利用這些機會，透過投資研發以及與科技公司建立策略夥伴關係來更快地創新。

然而，市場成長面臨挑戰，例如嚴格的監管要求需要時間來產品核可，以及先進診斷設備的高成本，這可能成為新興市場的障礙。診斷測試的潛在不準確性以及對資源匱乏地區醫療保健基礎設施的依賴也產生了限制。

您可以追求創新，例如開發可在偏遠地區和都市區使用的可攜式、經濟高效的設備，以及改進用於預測診斷的人工智慧演算法以幫助預防性護理。市場競爭激烈，龍頭企業紛紛透過併購來豐富產品線，充滿活力的成長環境已成熟。總體而言，持續投資於技術進步和遵守監管標準對於充分發揮心臟病診斷市場的潛力至關重要。

市場動態：快速發展的心臟病診斷市場的關鍵市場洞察

供需的動態交互作用正在改變心臟病診斷市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 年輕一代和成年人中心血管疾病的盛行率不斷增加
    • 消費者預防保健意識不斷增強
    • 增加久坐的生活方式
  • 市場限制因素
    • 心臟病診斷設備高成本
  • 市場機會
    • 醫學影像處理技術創新
    • 人工智慧和機器學習在心臟病診斷藥物中的部署
  • 市場挑戰
    • 缺乏技術精湛、經驗豐富的專業人員

波特的五力：駕馭心臟病診斷市場的策略工具

波特的五力框架是了解心臟病診斷市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對心臟病診斷市場的影響

外部宏觀環境因素在塑造心臟病診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解心臟病診斷藥物市場的競爭狀況

對心臟病診斷市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心臟病診斷市場供應商的績效評估

FPNV定位矩陣是評估心臟病診斷市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃心臟病診斷市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，心臟病診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 年輕人和成年人中心血管疾病的盛行率不斷增加
      • 提高消費者預防保健意識
      • 更採用久坐的生活方式
    • 抑制因素
      • 心臟病診斷設備高成本
    • 機會
      • 醫學影像技術創新
      • 在心臟病診斷中引入人工智慧和機器學習
    • 任務
      • 缺乏技術精湛、經驗豐富的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 心臟病診斷藥物市場測試

  • 驗血
  • 心臟超音波圖
  • 心電圖

第7章心臟病診斷市場：依最終用戶分類

  • 門診手術中心
  • 診斷中心
  • 醫院/診所

第8章 北美和南美心臟病診斷藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區心臟病診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲心臟病診斷藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories Inc.
  • ACS Diagnostics Inc.
  • Asahi Kasei Corporation
  • Bio-Rad Laboratories Inc.
  • Bionet Co., Ltd.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Danaher Corporation
  • F. Hoffmann La-Roche Ltd.
  • FUJIFILM Holdings Corp.
  • GE Healthcare Inc.
  • Hill Rom Holdings Inc. by Baxter International Inc.
  • Koninklijke Philips NV
  • Nihon Kohden Corp.
  • Siemens Healthineers AG
Product Code: MRR-3E376243AABD

The Heart Attack Diagnostics Market was valued at USD 13.97 billion in 2023, expected to reach USD 14.96 billion in 2024, and is projected to grow at a CAGR of 7.68%, to USD 23.47 billion by 2030.

The heart attack diagnostics market encompasses a range of tools and technologies designed to rapidly and accurately identify myocardial infarctions. The scope of this sector includes diagnostic tests such as electrocardiograms, blood tests for cardiac biomarkers like troponins, and advanced imaging techniques. Its necessity stems from the urgent need for early and precise detection to improve patient outcomes and reduce mortality rates. Applications of these diagnostics span emergency room settings, routine check-ups for at-risk individuals, and continuous monitoring technologies. In terms of end-use scope, hospitals, clinics, and research institutes are the primary users, though there's a rising trend towards personal health monitoring devices in home healthcare settings.

KEY MARKET STATISTICS
Base Year [2023] USD 13.97 billion
Estimated Year [2024] USD 14.96 billion
Forecast Year [2030] USD 23.47 billion
CAGR (%) 7.68%

Key growth factors include the increasing prevalence of cardiovascular diseases due to lifestyle changes, aging populations, and advancements in diagnostic technologies that offer faster results with higher accuracy. Emerging opportunities lie in the integration of artificial intelligence and machine learning to enhance diagnostic capabilities and the development of non-invasive and point-of-care testing solutions. Companies can capitalize on these opportunities by investing in R&D and forming strategic partnerships with technology firms to innovate faster.

However, market growth faces challenges such as the high cost of advanced diagnostic equipment, which can be a barrier in emerging markets, alongside stringent regulatory requirements that elongate product approval times. Limitations also arise from potential inaccuracies in diagnostic tests and dependence on healthcare infrastructure in low-resource settings.

Innovation can be pursued in creating portable, cost-effective devices suitable for both remote and urban areas, and improving AI algorithms for predictive diagnostics, which can aid in preventive healthcare. The market is highly competitive, with major players focusing on mergers and acquisitions to enhance their product offerings, indicating a dynamic environment ripe for growth. Overall, continued investment in technological advancement and meeting regulatory standards are essential to harness the full potential of the heart attack diagnostics market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Heart Attack Diagnostics Market

The Heart Attack Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of cardiovascular disease among younger and adult generation
    • Rising consumer awareness for preventive health
    • Higher adoption of sedentary lifestyles
  • Market Restraints
    • High cost of heart attack diagnostic equipments
  • Market Opportunities
    • Innovations in medical imaging technology
    • Deployment of AI and ML in heart attack diagnostics
  • Market Challenges
    • Lack of skilled and experienced professionals

Porter's Five Forces: A Strategic Tool for Navigating the Heart Attack Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Heart Attack Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Heart Attack Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Heart Attack Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Heart Attack Diagnostics Market

A detailed market share analysis in the Heart Attack Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Heart Attack Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Heart Attack Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Heart Attack Diagnostics Market

A strategic analysis of the Heart Attack Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Heart Attack Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., ACS Diagnostics Inc., Asahi Kasei Corporation, Bio-Rad Laboratories Inc., Bionet Co., Ltd., Boston Scientific Corporation, Canon Medical Systems Corporation, Danaher Corporation, F. Hoffmann La-Roche Ltd., FUJIFILM Holdings Corp., GE Healthcare Inc., Hill Rom Holdings Inc. by Baxter International Inc., Koninklijke Philips N.V., Nihon Kohden Corp., and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Heart Attack Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test, market is studied across Blood Tests, Echocardiogram, and Electrocardiogram.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostics Centers, and Hospital & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of cardiovascular disease among younger and adult generation
      • 5.1.1.2. Rising consumer awareness for preventive health
      • 5.1.1.3. Higher adoption of sedentary lifestyles
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of heart attack diagnostic equipments
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations in medical imaging technology
      • 5.1.3.2. Deployment of AI and ML in heart attack diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled and experienced professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Heart Attack Diagnostics Market, by Test

  • 6.1. Introduction
  • 6.2. Blood Tests
  • 6.3. Echocardiogram
  • 6.4. Electrocardiogram

7. Heart Attack Diagnostics Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Diagnostics Centers
  • 7.4. Hospital & Clinics

8. Americas Heart Attack Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Heart Attack Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Heart Attack Diagnostics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories Inc.
  • 2. ACS Diagnostics Inc.
  • 3. Asahi Kasei Corporation
  • 4. Bio-Rad Laboratories Inc.
  • 5. Bionet Co., Ltd.
  • 6. Boston Scientific Corporation
  • 7. Canon Medical Systems Corporation
  • 8. Danaher Corporation
  • 9. F. Hoffmann La-Roche Ltd.
  • 10. FUJIFILM Holdings Corp.
  • 11. GE Healthcare Inc.
  • 12. Hill Rom Holdings Inc. by Baxter International Inc.
  • 13. Koninklijke Philips N.V.
  • 14. Nihon Kohden Corp.
  • 15. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. HEART ATTACK DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. HEART ATTACK DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HEART ATTACK DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HEART ATTACK DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEART ATTACK DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEART ATTACK DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. HEART ATTACK DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. HEART ATTACK DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023